Left Ventricular Midwall Fibrosis as a Predictor of Mortality and Morbidity After Cardiac Resynchronization Therapy in Patients With Nonischemic Cardiomyopathy

Study Questions:

Does the presence of left ventricular mid-wall fibrosis in patients with nonischemic cardiomyopathy (NICM) undergoing cardiac resynchronization therapy (CRT) predict an increased risk of adverse events?